Interactions between taurine and ethanol in the central nervous system

Amino Acids

Volumn 23, Issue 4, 2002, Pages 345-357

  Olive, M Foster ^a  

^a UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

Acamprosate; Central nervous system (CNS); Ethanol; Locomotor activity; Sedation; Self administration; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 6 AMINOMETHYL 3 METHYL 4H 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; ACAMPROSATE; ALCOHOL; AMINO ACID DERIVATIVE; BETA ALANINE; BICUCULLINE; CALCIUM CHANNEL; CATION CHANNEL; CHLORIDE CHANNEL; DEXAMPHETAMINE; GLYCINE RECEPTOR; GLYCINE RECEPTOR ANTAGONIST; HOMOTAURINE; HYPOTAURINE; ISETHIONIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN INHIBITOR; STRYCHNINE; TAURINE; 4 AMINOBUTYRIC ACID; DRUG DERIVATIVE; DRUGS USED IN THE TREATMENT OF ADDICTION;

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ALLOSTERISM; ANIMAL BEHAVIOR; AVERSION; BLOOD BRAIN BARRIER; BRAIN LEVEL; BRAIN REGION; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME REGULATION; GABAERGIC TRANSMISSION; HUMAN; LOCOMOTION; MICRODIALYSIS; MOLECULAR INTERACTION; MOTIVATION; NEUROCHEMISTRY; NEUROMODULATION; NEUROPHARMACOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OPIATE ADDICTION; OSMOREGULATION; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REINFORCEMENT; RELAPSE; REVIEW; RIGHTING REFLEX; SEDATION; TREATMENT OUTCOME; ANIMAL; BEHAVIOR; CHEMISTRY; METABOLISM; MOTOR ACTIVITY;

ANIMALIA; STRYCHNOS TOXIFERA;

ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; BEHAVIOR; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; ETHANOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; MOTOR ACTIVITY; TAURINE;

EID: 0036451194     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-002-0203-1     Document Type: Review

References (173)

1. al Qatari M, Bouchenafa O, Littleton J (1998) Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 22: 810-814
2. al Qatari M, Khan S, Harris B, Littleton J (2001) Acamprosate is neuroprotective against glutamate-induced excitotoxicity when enhanced by ethanol withdrawal in neocortical cultures of fetal rat brain. Alcohol Clin Exp Res 25: 1276-1283
3. 2+ channels in cultured rat mesencephalic neurones. Naunyn-Schmied Arch Pharmacol 362: 440-443
4. Almarghini K, Remy A, Tappaz M (1991) Immunocytochemistry of the taurine biosynthesis enzyme, cysteine sulfinate decarboxylase, in the cerebellum: Evidence for a glial localization. Neuroscience 43: 111-119
5. Aragon CM, Amit Z (1993) Taurine and ethanol-induced conditioned taste aversion. Pharmacol Biochem Behav 44: 236-263
6. Aragon CM, Trudeau LE, Amit Z (1992) Effect of taurine on ethanol-induced changes in open-field locomotor activity. Psychopharmacology 107: 337-340
7. Asin KE, Wirtshafter D, Tabakoff B (1985) Failure to establish a conditioned place preference with ethanol in rats. Pharmacol Biochem Behav 22: 169-173
8. Barbeau A, Inoue N, Tsukada Y, Butterworth RF (1975) The neuropharmacology of taurine. Life Sci 17: 669-677
9. Benrabh H, Bourre JM, Lefauconnier JM (1995) Taurine transport at the blood-brain barrier: An in vivo brain perfusion study. Brain Res 692: 57-65
10. Berton F, Francesconi WG, Madamba SG, Zieglgänsberger W, Siggins GRF (1998) Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons. Alcohol Clin Exp Res 22: 183-191
11. Blomqvist O, Soderpalm B, Engel JA (1992) Ethanol-induced locomotor activity: Involvement of central nicotinic acetylcholine receptors? Brain Res Bull 29: 173-178
12. Boggan WO, Medberry C, Hopkins DH (1978) Effect of taurine on some pharmacological properties of ethanol. Pharmacol Biochem Behav 9: 469-472
13. Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre JP, Chretien P, Durlach J (1984) A homotaurine derivative reduces the voluntary intake of ethanol by rats: Are cerebral GABA receptors involved? Pharmacol Biochem Behav 21: 787-789
14. Bolo N, Nédélec JF, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP (1998) Central effects of acamprosate: Part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers. Psychiatry Res 82: 115-127
15. Bozarth MA (1990) Evidence for the rewarding effects of ethanol using the conditioned place preference method. Pharmacol Biochem Behav 35: 485-487
16. Buck KJ, Harris RA (1991) Neuroadaptive responses to chronic ethanol. Alcohol Clin Exp Res 15: 460-470
17. A receptors in mammalian brain in vitro. Eur J Pharmacol 207: 9-16
18. Carlen PL, Jahromi SS, Valiante TA, Velumian AA, Weiner JL, Zhang L (1993) The role of calcium homeostasis and calcium currents in ethanol actions on central mammalian neurons. Alcohol Alcohol [Suppl 2]: 395-401
19. Catlin MC, Guizzetti M, Costa LG (1999) Effects of ethanol on calcium homeostasis in the nervous system: Implications for astrocytes. Mol Neurobiol 19: 1-24
20. Chabenat C, Chretien P, Daoust M, Moore N, Andre D, Lhuintre JP, Saligaut C, Boucly P, Boismare F (1988) Physico-chemical, pharmacological and pharmacokinetic study of a new GABAergic compound, calcium acetylhomotaurinate. Meth Find Exp Clin Pharmacol 10: 311-317
21. Cole JC, Littleton JM, Little HJ (2000) Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze. Psychopharmacology 147: 403-411
22. Cott J, Carlsson A, Engel J, Lindqvist M (1976) Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmied Arch Pharmacol 295: 203-209
23. Crews F, Morrow AL, Criswell H, Breese GR (1996) Effects of ethanol on ion channels. Int Rev Neurobiol 39: 283-367
24. Cunningham CL (1981) Spatial aversion conditioning with ethanol. Pharmacol Biochem Behav 14: 263-264
25. Cunningham CL, Henderson CM (2000) Ethanol-induced conditioned place aversion in mice. Behav Pharmacol 11: 591-602
26. Cunningham CL, Fidler TL, Hill KG (2000) Animal models of alcohol's motivational effects. Alcohol Res Health 24: 85-92
27. Curtis DR, Hosli L, Johnston GA (1968a) A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res 6: 1-18
28. Curtis DR, Hosli L, Johnston GA, Johnston IH (1968b) The hyperpolarization of spinal motoneurones by glycine and related amino acids. Exp Brain Res 5: 235-258
29. Czachowski CL, Legg BH, Samson HH (2001) Effects of acamprosate on ethanol-seeking and self-administration in the rat. Alcohol Clin Exp Res 25: 344-350
30. Dahchour A, De Witte P (1999) Acamprosate decreases the hypermotility during repeated ethanol withdrawal. Alcohol 18: 77-81
31. Dahchour A, De Witte P (2000a) Ethanol and amino acids in the central nervous system: Assessment of the pharmacological actions of acamprosate. Prog Neurobiol 60: 343-362
32. Dahchour A, De Witte P (2000b) Taurine blocks the glutamate increase in the nucleus accumbens microdialysate of ethanol-dependent rats. Pharmacol Biochem Behav 65: 345-350
33. Dahchour A, Quertemont E, De Witte P (1994) Acute ethanol increases taurine but neither glutamate nor GABA in the nucleus accumbens of male rats: A microdialysis study. Alcohol Alcohol 29: 485-487
34. Dahchour A, Durbin P, De Witte P (1995) Ethanol and acamprosate increase the extracellular taurine in the nucleus accumbens: A microdialysis study. Alcohol Alcohol 30: 483
35. Dahchour A, Quertemont E, De Witte P (1996) Taurine increases in the nucleus accumbens microdialysate after acute ethanol administration to naive and chronically alcoholised rats. Brain Res 735: 9-19
36. Dahchour A, De Witte P, Bolo N, Nédélec JF, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate: Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 82: 107-114
37. Dahchour A, Hoffman A, Deitrich R, De Witte P (2000) Effects of ethanol on extracellular amino acid levels in high- and low-alcohol sensitive rats: A microdialysis study. Alcohol Alcohol 35: 548-553
38. Daoust M, Lhuintre JP, Saligaut C, Moore N, Flipo JL, Boismare F (1987) Noradrenaline and GABA brain receptors are co-involved in the voluntary intake of ethanol by rats. Alcohol Alcohol [Suppl 1]: 319-322
39. Daoust M, Legrand E, Gewiss M, Heidbreder C, De Witte P, Tran G, Durbin P (1992) Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats. Pharmacol Biochem Behav 41: 669-674
40. B receptors in rat hippocampal CA1 area. Brain Res 864: 298-307
41. Epstein EE, Kahler CW, McCrady BS, Lewis KD, Lewis S (1995) An empirical classification of drinking patterns among alcoholics: Binge, episodic, sporadic, and steady. Addict Behav 20: 23-41
42. Fadda F, Rossetti ZL (1998) Chronic ethanol consumption: From neuroadaptation to neurodegeneration. Prog Neurobiol 56: 385-431
43. Ferko AP (1987) Ethanol-induced sleep time: Interaction with taurine and a taurine antagonist. Pharmacol Biochem Behav 27: 235-238
44. Ferko AP, Bobyock E (1988) Effect of taurine on ethanol-induced sleep time in mice genetically bred for differences in ethanol sensitivity. Pharmacol Biochem Behav 31: 667-673
45. Font L, Miquel M, Aragon CMG (2001) Behavioral consequences of the hypotaurine-ethanol interaction. Pharmacol Biochem Behav 70: 333-339
46. Frye GD, Breese GR (1981) An evaluation of the locomotor stimulating action of ethanol in rats and mice. Psychopharmacology 75: 372-379
47. Gandhi CR, Ross DH (1989) Influence of ethanol on calcium, inositol phospholipids and intracellular signalling mechanisms. Experientia 45: 407-413
48. Gauvin DV, Holloway FA (1992) Historical factors in the development of ETOH-conditioned place preference. Alcohol 9: 1-7
49. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol 26: 129-137
50. Girard Y, Atkinson JG, Haubrich DR, Williams M, Yarbrough GG (1982) Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist. J Med Chem 25: 113-116
51. Gonzalez LP (1998) Electrophysiological changes after repeated alcohol withdrawal. Alcohol Health Res 22: 34-37
52. Grant KA, Woolverton WL (1989) Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals. Pharmacol Biochem Behav 32: 607-611
53. Grant KA, Valverius P, Hudspith M, Tabakoff B (1990) Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 176: 289-296
54. Gulya K, Grant KA, Valverius P, Hoffman PL, Tabakoff B (1991) Brain regional specificity and time-course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res 547: 129-134
55. Gustavsson L (1990) Brain lipid changes after ethanol exposure. Ups J Med Sci [Suppl 48]: 245-266
56. Haas HL, Hösli L (1973) The depression of brain stem neurones by taurine and its interaction with strychnine and bicuculline. Brain Res 52: 399-402
57. Harris RA (1999) Ethanol actions on multiple ion channels: Which are important? Alcohol Clin Exp Res 23: 1563-1570
58. Häusser MA, Yung WH, Lacey MG (1992) Taurine and glycine activate the same Cl-conductance in substantia nigra dopamine neurones. Brain Res 571: 103-108
59. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18: 125-133
60. A receptor modulators and alcohol in mice lacking PKCε. Nature Neurosci 2: 997-1002
61. Hoffman PL, Tabakoff B (1991) The contribution of voltage-gated and NMDA receptor-gated calcium channels to ethanol withdrawal seizures. Alcohol Alcohol [Suppl 1]: 171-175
62. Holloway FA, King DA, Bedingfield JB, Gauvin DV (1992) Role of context in ethanol tolerance and subsequent hedonic effects. Alcohol 9: 109-116
63. Holloway FA, Bird DC, Devenport JA (1984) Periodic availability: Factors affecting alcohol selection in rats. Alcohol 1: 19-25
64. Hölter SM, Landgraf R, Zieglgansberger W, Spanagel R (1997) Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21: 862-868
65. Hunt T, Amit Z (1987) Conditioned taste aversion induced by self-administered drugs: Paradox revisited. Neurosci Biobehav Rev 11: 107-130
66. Huxtable RJ (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32: 471-533
67. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72: 101-163
68. Ida S, Hikichi M (1976) Effect of taurine on ethanol-induced sleeping time in mice. J Stud Alcohol 37: 19-26
69. Ida S, Kuriyama K, Tomida Y, Kimura H (1987) Antisera against taurine: Quantitative characterization of the antibody specificity and its application to immunohistochemical study in the rat brain. J Neurosci Res 18: 626-631
70. Iwata H, Matsuda T, Lee E, Yamagami S, Baba A (1980) Effect of ethanol on taurine concentration in the brain. Experientia 36: 332-333
71. Iwata H, Nakayama K, Matsuda T, Baba A (1984) Effect of taurine on a benzodiazepine-GABA-chloride ionophore receptor complex in rat brain membranes. Neurochem Res 9: 535-544
72. Jacobson I, Hamberger A (1984) Veratridine-induced release in vivo and in vitro of amino acids in the rabbit olfactory bulb. Brain Res 299: 103-112
73. Jacobson I, Sandberg M, Hamberger A (1985) Mass transfer in brain dialysis devices - A new method for the estimation of extracellular amino acids concentration. J Neurosci Meth 15: 263-268
74. Johnson BA, Ait-Daoud N (2000) Neuropharmacological treatments for alcoholism: Scientific basis and clinical findings. Psychopharmacology 149: 327-344
75. Kontro P, Oja SS (1990) Interactions of taurine with GABAB binding sites in mouse brain. Neuropharmacology 29: 243-247
76. B receptors in the brain. Prog Clin Biol Res 351: 83-94
77. Kranzler HR (2000) Pharmacotherapy of alcoholism: Gaps in knowledge and opportunities for research. Alcohol Alcohol 35: 537-547
78. Kratzer U, Schmidt WJ (1998) The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Neurosci Lett 252: 53-56
79. Kudo Y, Akiyoshi E, Akagi H (1988) Identification of two taurine receptor subtypes on the primary afferent terminal of frog spinal cord. Br J Pharmacol 94: 1051-1056
80. Kurachi M, Aihara H (1985) The action of taurine on the response to glutamate in the motoneuron of the isolated frog spinal cord. Neuropharmacology 24: 775-781
81. Kurachi M, Yoshihara K, Aihara H (1983) Effect of taurine on depolarizations induced by L-glutamate and other excitatory amino acids in the isolated spinal cord of the frog. Jap J Pharmacol 33: 1247-1254
82. Kuriyama K (1980) Taurine as a neuromodulator. Fed Proc 39: 2680-2684
83. Lehmann A, Hegberg H, Hamberger A (1984) A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neurosci Lett 52: 341-346
84. Le Magnen J, Tran G, Durlach J (1987a) Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats. Alcohol 4: 103-108
85. Le Magnen J, Tran G, Durlach J, Martin C (1987b) Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. Alcohol 4: 97-102
86. Lewis MJ, June HL (1990) Neurobehavioral studies of ethanol reward and activation. Alcohol 7: 213-219
87. Lewis CA, Ahmed Z, Faber DS (1991) A characterization of glycinergic receptors present in cultured rat medullary neurons. J Neurophysiol 66: 1291-1303
88. Lhuintre JP, Daoust M, Moore ND, Chretien P, Saligaut C, Tran G, Bosimare F, Hillemand B (1985) Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1 (8496): 1014-1016
89. Lhuintre JP, Moore N, Tran G, Steru L, Langrenon S, Daoust M, Parot P, Ladure P, Libert C, Boismare F, et al (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 25: 613-622
90. Linseman MA (1987) Alcohol consumption in free-feeding rats: Procedural, genetic and pharmacokinetic factors. Psychopharmacology 92: 254-261
91. Little HJ (1999) The contribution of electrophysiology to knowledge of the acute and chronic effects of ethanol. Pharmacol Ther 84: 333-353
92. Littleton J (1995) Acamprosate in alcohol dependence: How does it work? Addiction 90: 1179-1188
93. Littleton J (1998) Neurochemical mechanisms underlying alcohol withdrawal. Alcohol Health Res 22: 13-24
94. Lombardini JB (1994) The inhibitory effects of taurine on protein phosphorylation: Comparison of various characteristics of the taurine-affected phosphoproteins present in rat retina, brain and heart. Adv Exp Med Biol 359: 9-17
95. Madamba SG, Schweitzer P, Zieglgänsberger W, Siggins GR (1996) Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcohol Clin Exp Res 20: 651-658
96. Madsen S, Ottersen OP, Storm-Mathisen J (1985) Immunocytochemical visualization of taurine: Neuronal localization in the rat cerebellum. Neurosci Lett 60: 255-260
97. Malminen O, Kontro P (1986) Modulation of the GABA-benzodiazepine receptor complex by taurine in rat brain membranes. Neurochem Res 11: 85-94
98. Malminen O, Kontro P (1989) Gamma-aminobutyric acid and benzodiazepine receptors in cultured cerebellar granule cells: Effects of taurine and its lipophilic derivatives. Neuropharmacology 28: 907-912
99. Marcucella H, Munro I, MacDonall JS (1984) Patterns of ethanol consumption as a function of the schedule of ethanol access. J Pharmacol Exp Ther 230: 658-664
100. Mason BJ (2001) Treatment of alcohol-dependent outpatients with acamprosate: A clinical review. J Clin Psychiatry 62 [Suppl 20]: 42-48
101. Mason ST, Corcoran ME, Fibiger HC (1979) Noradrenergic processes involved in the locomotor effects of ethanol. Eur J Pharmacol 54: 383-387
102. Mas-Serrano P, Granero L, Martin-Algarra RV, Guerri C, Polache A (2000) Kinetic study of acamprosate absorption in rat small intestine. Alcohol Alcohol 35: 324-330
103. Mattucci-Schiavone L, Ferko AP (1985) Acute effects of taurine and a taurine antagonist on ethanol-induced central nervous system depression. Eur J Pharmacol 113: 275-278
104. Mayer ML (1981) Inhibitory actions of amino acids in the preoptic-anterior hypothalamus of the rat. Exp Brain Res 43: 154-158
105. McBride WJ, Frederickson RC (1980) Taurine as a possible inhibitory transmitter in the cerebellum. Fed Proc 39: 2701-2705
106. McBroom MJ, Elkhawad AO, Dlouha H (1986) Taurine and ethanol-induced sleeping time in mice: Route and time course effects. Gen Pharmacol 17: 97-100
107. Medina JH, De Robertis E (1984) Taurine modulation of the benzodiazepine-gamma-aminobutyric acid receptor complex in brain membranes. J Neurochem 42: 1212-1217
108. Mendelson JH, Mello NK (1966) Experimental analysis of drinking behavior of chronic alcoholics. Ann N Y Acad Sci 133: 828-845
109. Milton GV, Randall PK, Erickson CK (1995) Low-dose effect of ethanol on locomotor activity induced by activation of the mesolimbic system. Alcohol Clin Exp Res 19: 768-776
110. Miquel M, Correa M, Sanchis-Segura C, Aragon CMG (1999) The ethanol-induced open-field activity in rodents treated with isethionic acid acid, a central metabolite of taurine. Life Sci 64: 1613-1621
111. Naassila M, Legrand E, d'Alche-Birée F, Daoust M (1998) Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice. Psychopharmacology 140: 421-428
112. Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M (1998) Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 22: 802-809
113. Naassila M, Beauge FJ, Sebire N, Daoust M (2000) Intracerebroventricular injection of antisense oligos to nNOS decreases rat ethanol intake. Pharmacol Biochem Behav 67: 629-636
114. Oja SS, Kontro P (1990) Neuromodulatory and trophic actions of taurine. Prog Clin Biol Res 351: 69-76
115. Oja SS, Saransaari P (1996) Taurine as osmoregulator and neuromodulator in the brain. Metabol Brain Dis 11: 153-164
116. Okamoto K, Sakai Y (1980) Localization of sensitive sites to taurine, gamma-aminobutyric acid, glycine and beta-alanine in the molecular layer of guinea-pig cerebellar slices. Br J Pharmacol 69: 407-413
117. Okamoto K, Kimura H, Sakai Y (1983a) Effects of taurine and GABA on Ca spikes and Na spikes in cerebellar purkinje cells in vitro: Intrasomatic study. Brain Res 260: 249-259
118. Okamoto K, Kimura H, Sakai Y (1983b) Evidence for taurine as an inhibitory neurotransmitter in cerebellar stellate interneurons: Selective antagonism by TAG (6-aminomethyl-3-methyl-4H,1,2,4-benzothiadiazine-1,1-dioxide). Brain Res 265: 163-168
119. Okamoto K, Kimura H, Sakai Y (1983c) Ionic mechanisms of the action of taurine on cerebellar Purkinje cell dendrites in vitro: Intradendritic study. Brain Res 260: 261-269
120. Olive MF, Hodge CW (2001) Taurine-related compounds differentially alter ethanol consumption and ethanol-stimulated dopamine release in rats: Comparison with acamprosate. Alcohol Clin Exp Res 25: 17A
121. Olive MF, Mehmert KK, Hodge CW (2000a) Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor. Eur J Pharmacol 409: 291-294
122. Olive MF, Mehmert KK, Messing RO, Hodge CW (2000b) Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCε deficient mice. Eur J Neurosci 12: 4131-4140
123. Palkovits M, Elekes I, Lang T, Patthy A (1986) Taurine levels in discrete brain nuclei of rats. J Neurochem 47: 1333-1335
124. Pandey SC (1998) Neuronal signaling systems and ethanol dependence. Mol Neurobiol 17: 1-15
125. Pascucci T, Cioli I, Pisetzky F, Dupre S, Spirito A, Nencini P (1999) Acamprosate does not antagonise the discriminative stimulus properties of amphetamine and morphine in rats. Pharmacol Res 40: 333-338
126. Popp RL, Lovinger DM (2000) Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons. Eur J Pharmacol 394: 221-231
127. Putzke J, Spanagel R, Tolle TR, Zieglgansberger W (1996) Anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal. Eur J Pharmacol 317: 39-48
128. Quertemont E, de Neuville J, De Witte P (1998a) Changes in the amygdala amino acid microdialysate after conditioning with a cue associated with ethanol. Psychopharmacology 139: 71-78
129. Quertemont E, Goffaux V, Vlaminck A-M, Wolf C, De Witte P (1998b) Oral taurine supplementation modulates ethanol-conditioned stimulus preference. Alcohol 16: 201-206
130. Quertemont E, Dahchour A, Ward RJ, De Witte P (1999) Ethanol induces taurine release in the amygdala: An in vivo microdialysis study. Addict Biol 4: 47-54
131. Quertemont E, De Witte P (2001) Conditioned stimulus preference after acetaldehyde but not ethanol injections. Pharmacol Biochem Behav 68: 449-454
132. A receptor. Prog Clin Biol Res 351: 121-127
133. Quinn MR, Harris CL (1995) Taurine allosterically inhibits binding of [35S]-t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes. Neuropharmacology 34: 1607-1613
134. Quinn MR, Miller CL (1992) Taurine allosterically modulates flunitrazepam binding to synaptic membranes. J Neurosci Res 33: 136-141
135. Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgansberger W, Schadrack J (2001) The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Neuropharmacology 40: 749-760
136. Reid LD, Hunter GA, Beaman CM, Hubbell CL (1985) Toward understanding ethanol's capacity to be reinforcing: A conditioned place preference following injections of ethanol. Pharmacol Biochem Behav 22: 483-487
137. Rossetti ZL, Carboni S (1995) Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 283: 177-183
138. Rossetti ZL, Carboni S, Fadda F (1999) Glutamate-induced increase of extracellular glutamate through N-methyl-D-aspartate receptors in ethanol withdrawal. Neuroscience 93: 1135-1140
139. Saitz R (1998) Introduction to alcohol withdrawal. Alcohol Health Res 22: 5-12
140. Saivin S, Hulot T, Chabac S, Potgieter A, Durbin P, Houin G (1998) Clinical pharmacokinetics of acamprosate. Clin Pharmacokinetics 35: 331-345
141. Samson HH (1986) Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res 10: 436-442
142. Samson HH, Tolliver GA, Schwarz-Stevens K (1991) Ethanol self-administration in a nonrestricted access situation: Effect of ethanol initiation. Alcohol 8: 43-53
143. Saransaari P, Oja SS (2000) Taurine and neural cell damage. Amino Acids 19: 509-526
144. Smith BR, Amit Z, Splawinsky J (1984) Conditioned place preference induced by intraventricular infusions of acetaldehyde. Alcohol 1: 193-195
145. Spanagel R, Hölter SM (2000) Pharmacological validation of a new animal model of alcoholism. J Neural Trans 107: 669-680
146. Spanagel R, Zieglgansberger W (1997) Anti-craving compounds for ethanol: New pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54-59
147. Spanagel R, Hölter SM, Allingham K, Landgraf R, Zieglgänsberger W (1996a) Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305: 39-44
148. Spanagel R, Putzke J, Stefferl A, Schobitz B, Zieglgansberger W (1996b) Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305: 45-50
149. Spanagel R, Zieglgansberger W, Hundt W (1996c) Acamprosate and alcohol: III. Effects of alcohol discrimination in the rat. Eur J Pharmacol 305: 51-56
150. Spanagel R, Sillaber I, Zieglansberger W, Corrigall WA, Stewart J, Shaham Y (1998) Acamprosate suppresses the expression of morphine-induced sensitization in rats but does not affect heroin self-administration or relapse induced by heroin or stress. Psychopharmacology 139: 391-401
151. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP (2001) Effect of acamprosate and naltrexone, along or in combinations, on ethanol consumption. Alcohol 23: 109-116
152. Strombom UH, Liedman B (1982) Role of dopaminergic neurotransmission in locomotor stimulation by dexamphetamine and ethanol. Psychopharmacology 78: 271-276
153. Stubbs CD, Slater SJ (1999) Ethanol and protein kinase C. Alcohol Clin Exp Res 23: 1552-1560
154. Taber KH, Lin CT, Liu JW, Thalmann RH, Wu JY (1986) Taurine in hippocampus: Localization and postsynaptic action. Brain Res 386: 113-121
155. Tamai I, Senmaru M, Terasaki T, Tsuji A (1995) Na(+)- and Cl(-)-dependent transport of taurine at the blood-brain barrier. Biochem Pharmacol 50: 1783-1793
156. Theofanopoulos V, Lau-Cam CA (1998a) The effects of taurine and biogenetically related sulfur-containing compounds on the metabolism of and hypothermia by ethanol in the rat. Adv Exp Med Biol 442: 299-307
157. Theofanopoulos V, Lau-Cam CA (1998b) Modification by taurine of the metabolism and hypothermic effect of ethanol in the rat. Adv Exp Med Biol 442: 309-318
158. Tsai G, Coyle JT (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173-184
159. van der Kooy D, O'Shaughnessy M, Mucha RF, Kalant H (1983) Motivational properties of ethanol in naive rats as studied by place conditioning. Pharmacol Biochem Behav 19: 441-445
160. Ward RJ, Colantuoni C, Dahchour A, Quertemont E, De Witte P (1997) Acetaldehyde-induced changes in the monoamine and amino acid extracellular microdialysate content of the nucleus accumbens. Neuropharmacology 36: 225-232
161. Ward RJ, Marshall EJ, Ball D, Martinez J, De Witte P (1999) Homeostasis of taurine and glutamate plasma levels after acute and chronic ethanol administration in man. Neurosci Res Comm 24: 41-49
162. Ward RJ, Kest W, Bruyeer P, Lallemand F, De Witte P (2001) Taurine modulates catalase, aldehyde dehydrogenase, and ethanol elimination rates in rat brain. Alcohol Alcohol 36: 39-43
163. Watanabe A, Hobara N, Nagashima H (1985) Lowering of liver acetaldehyde but not ethanol concentrations by pretreatment with taurine in ethanol-loaded rats. Experientia 41: 1421-1422
164. Whittington MA, Lambert JD, Little HJ (1995) Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol 30: 105-114
165. Wilde MI, Wagstaff AJ (1997) Acamprosate: A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs 53: 1038-1053
166. Williams M, Risley EA, Totaro JA (1980) Interactions of taurine and beta-alanine with central nervous system neurotransmitter receptors. Life Sci 26: 557-560
167. Wu JY, Liao CC, Lin CJ, Lee YH, Ho JY, Tsai WH (1990) Taurine receptor in the mammalian brain. Prog Clin Biol Res 351: 147-156
168. Wu JY, Jin H, Schloss TV, Faiman MD, Ningaraj NS, Foos T, Chen W (2001) Neurotoxic effect of acamprosate, n-acetyl-homotaurine, in cultured neurons. J Biomed Sci 8: 96-103
169. Yarbrough GG, Singh DK, Taylor DA (1981) Neuropharmacological characterization of a taurine antagonist. J Pharmacol Exp Ther 219: 604-613
170. Yoshida M, Karasawa N, Ito M, Sakai M, Nagatsu I (1986) Demonstration of taurine-like immunoreactive structures in the rat brain. Neurosci Res 3: 356-363
171. Yoshida M, Teramura M, Karasawa N, Sakai M, Nagatsu I (1987) Immunohistochemistry of taurine and GABA in serial brain sections of the rat. Biogen Amines 4: 135-144
172. Zeise ML, Kasparow S, Capogna M, Zieglgänsberger W (1990) Calciumdiacetylhomotaurinate (CA-AOTA) decreases the action of excitatory amino acids in the rat neocortex in vitro. Prog Clin Biol Res 351: 237-242
173. Zeise ML, Kasparov S, Capogna M, Zieglgänsberger W (1993) Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: Possible involvement of excitatory amino acid receptors. Eur J Pharmacol 231: 47-52